Previous studies stated that YY1 can contribute to angiogenesis and other hallmarks of cancer through the activation of epidermal growth factor receptor (EGFR) and human epidermal growth factor 2 (HER2) (Guo et al. 2020). The gene discussed is EGFR; the disease is cancer.